Literature DB >> 27603007

Physical Symptoms at the Time of Dying Was Diagnosed: A Consecutive Cohort Study To Describe the Prevalence and Intensity of Problems Experienced by Imminently Dying Palliative Care Patients by Diagnosis and Place of Care.

Katherine Clark1,2, Alanna Connolly3, Sabina Clapham3, Karen Quinsey3, Kathy Eagar3,4, David C Currow5.   

Abstract

OBJECTIVE: The aim of this work was to analyze routine assessments recorded, when a patient was documented as likely to die in hours to days, to determine the prevalence, intensity, and associations of physical symptoms.
BACKGROUND: Although death inevitably occurs, very little prospective data describe at population level the physical symptoms confronting imminently dying people.
METHODS: Using prospectively collected data from participating palliative care services in the Australian Palliative Care Outcomes Collaboration between July 1, 2013, and December 31, 2014, factors associated with worse symptom experiences were explored using logistic regression modeling.
RESULTS: The experiences of 18,975 patients who died after being identified as imminently terminal were analyzed, with 75% (n = 14,238) of these being cancer deaths. Seventy percent (n = 13,051) occurred in a palliative care unit, 8.7% (n = 1657) in an acute hospital with palliative care support, and 22.5% (n = 4266) at home. More than half were assessed as experiencing acceptable symptom control especially those with nonmalignant disease. The notable exception was breathing problems, where compared to cancer patients, those with nonmalignant disease were 34% more likely to experience distressing breathlessness (odds ratio 1.34; 95% confidence interval 1.23-147). Regardless of the cause, deaths in a community setting were more likely to be complicated by more severe symptoms with the exception of breathlessness, where those dying in acute hospitals were most likely to be assessed as requiring further help. DISCUSSION: The terminal phase is perceived as a time where the majority will experience distressing symptoms, but this work suggests a contrary view. However, there did seem to be a detrimental effect depending on place of care with more significant problems recorded when people were dying at home. More work is needed to clarify this given the current push for more home deaths.

Entities:  

Mesh:

Year:  2016        PMID: 27603007     DOI: 10.1089/jpm.2016.0219

Source DB:  PubMed          Journal:  J Palliat Med        ISSN: 1557-7740            Impact factor:   2.947


  5 in total

Review 1.  Care at the Very End-of-Life: Dying Cancer Patients and Their Chosen Family's Needs.

Authors:  Katherine Clark
Journal:  Cancers (Basel)       Date:  2017-01-24       Impact factor: 6.639

2.  Symptom management, nutrition and hydration at end-of-life: a qualitative exploration of patients', carers' and health professionals' experiences and further research questions.

Authors:  Jessica Baillie; Despina Anagnostou; Stephanie Sivell; Jordan Van Godwin; Anthony Byrne; Annmarie Nelson
Journal:  BMC Palliat Care       Date:  2018-04-16       Impact factor: 3.234

3.  Development and Validity of the Nursing Care Scale and Nurse's Difficulty Scale in Caring for Dying Patients With Cancer and Their Families in General Hospitals in Japan.

Authors:  Yusuke Kanno; Kazuki Sato; Megumi Shimizu; Yuko Funamizu; Hideaki Andoh; Megumi Kishino; Tomomi Senaga; Tetsu Takahashi; Mitsunori Miyashita
Journal:  J Hosp Palliat Nurs       Date:  2019-04       Impact factor: 1.918

Review 4.  Palliative Care Within the Primary Health Care Setting in Australia: A Scoping Review.

Authors:  Deborah van Gaans; Katrina Erny-Albrecht; Jennifer Tieman
Journal:  Public Health Rev       Date:  2022-09-06

5.  Physical and psychological symptoms and signs in dying digestive tract cancer patients: the East Asian collaborative cross-cultural Study to Elucidate the Dying process (EASED).

Authors:  Jinyoung Shin; Sun Hyun Kim; Sang-Yeon Suh; Shao-Yi Cheng; Ping-Jen Chen; Takashi Yamaguchi; Tatsuya Morita; Satoru Tsuneto; Masanori Mori
Journal:  Support Care Cancer       Date:  2020-11-10       Impact factor: 3.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.